Immunobiogram® launches in Mexico thanks to a partnership between Biohope and Grupo Vanquish
Biohope Scientific Solutions for Human Health and Grupo Vanquish announce the launch of Immunobiogram® in Mexico, a milestone that marks a new step in the international expansion of this innovative immunology diagnostic solution.
From this month, Immunobiogram® is available in Mexico, offering healthcare professionals a tool that provides functional information on how each patient responds to immunosuppressive treatments. This approach enables progress towards more personalised medicine, supporting clinical decision-making with information tailored to each patient.
The launch is the result of a strategic collaboration between Biohope, a Spanish company specialising in precision in vitro diagnostics, and Grupo Vanquish, a Mexican company with a solid track record in introducing innovative technologies into the country’s healthcare system.
For Biohope, the arrival of Immunobiogram® in Mexico reinforces its mission to bring precision medicine into real-world clinical practice across various international markets. For Vanquish, it means expanding its offering with a differentiated solution, in line with its commitment to innovation and the continuous improvement of healthcare.
Both companies share the vision that precision diagnostics is a key driver for improving clinical outcomes and contributing to more efficient healthcare systems. The launch of Immunobiogram® in Mexico is a firm step in that direction.
